Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Therapeutic Approaches for Tumors With RAS Gene Mutations

NCT06229340 is registered in ClinicalTrials.gov with N.N. Petrov National Medical Research Center of Oncology as lead sponsor.

NCT NCT06229340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06229340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Therapeutic Approaches for Tumors With RAS Gene Mutations
Lead sponsor
N.N. Petrov National Medical Research Center of Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
October 3, 2023
Completion date
October 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer recurrent, lung cancer, melanoma, pancreas cancer, ras (kras or nras) gene mutation, ras mutation, refractory cancer